Lung patients made sick in a good cause
Researcher Barbro Melgert of the UG and her colleague René Lutter from the AMC Amsterdam are deliberately infecting thirty people with COPD and asthma with a mild variant of the common cold. The result with these people will be a minor lung attack, but for Melgert and Lutter this is an essential step in their research on lung attacks.
During a lung attack, the lungs stop functioning properly. People get so short of breath that they cannot breathe properly any more. The symptoms occur very suddenly, usually during a cold, and are very severe. Patients often have to go to hospital to be given extra oxygen. A lung attack is one of the most important causes of death for lung patients, but why some lung patients hjave an attack during a cold while others do not is still a mystery. Melgert and Lutter hope that their research, funded by the Longfonds (Lung Fund), will provide more insight into lung attacks, and in the long run result in the development of a new drug.
More information
- Barbro Melgert
-
Longaanval voorkomen [Preventing lung attacks], a Dutch article on Melgert's research
University of Groningen videos
The weekly online video magazine Unifocus highlights topics related to the University of Groningen in the fields of research and society, student life, teaching, policy and internationalization.
You can find more videos in our video portal.
Last modified: | 24 September 2021 1.26 p.m. |
More news
-
14 July 2025
ERC Proof of Concept grant for Kottapalli and Covi
Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).
-
10 July 2025
Dutch Research Agenda funding for nanomedicine research
Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.
-
10 July 2025
Dutch research Agenda funding for circular bio-based materials
Prof Anastasiia Krushynska has been granted a EUR 600,000 National Science Agenda (NWA) funding to help develop innovative technologies for converting low-grade organic waste into durable, recyclable materials.